Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07121335Recruiting
SABR for limited metastatic cancer
This trial tests a precise, high-dose radiation treatment (SABR) for people whose cancer has spread to a few spots (up to 5) and is not growing in the brain or been previously treated with radiation in those same spots.
SeoulAges 18 years+ - NCT06975748RecruitingPhase 2
Eye Drop for Nerve-Damaged Corneas
This trial tests an experimental eye drop (STSP-0902) for a condition called neurotrophic keratitis, where the cornea (the clear front part of the eye) gets scratches or sores because nerves are damaged. The drop contains a growth factor to help the eye heal. You might be eligible if you have a persistent scratch or sore on your cornea that has not improved for at least a week.
Jinan, ShandongAges 18–85 - NCT07453082Recruiting
A study on miRNA371 for newly diagnosed germ cell tumors
This study is looking at a new marker called miRNA371 in people newly diagnosed with germ cell tumors. The goal is to see if it can help predict relapse and guide treatment decisions.
Candiolo, TurinAges 18 years+ - NCT07451470Recruiting
Comparing two airway devices for stomach air in children during short surgeries
This trial compares two devices used to help children breathe during surgery (LarySeal Pro and Ambu AuraGain). It measures how much air gets into the stomach, which can cause discomfort. It is for children aged 6–12 having short elective surgeries (1 hour or less).
Cairo, Cairo GovernorateAges 6–10 - NCT07452250RecruitingPhase 2
Ferumoxytol-enhanced MRI for vein problems
This trial uses a special iron-based contrast agent called ferumoxytol during an MRI scan to get clearer pictures of your veins. It's for people who may have vein blockages or other vein issues that need better imaging.
Nanjing, JiangsuAges 18 years+ - NCT07443397RecruitingPhase 3
Anlotinib plus whole-brain radiation for SCLC brain metastases
This trial tests whether combining Anlotinib (a targeted drug that blocks tumor blood vessel growth) with whole-brain radiation can better control brain metastases in small cell lung cancer patients. It is for people with up to 10 brain tumors who have not had brain radiation before.
Beijing, Beijing MunicipalityAges 18–80 - NCT07423338Recruiting
Monitoring breathing muscles in respiratory failure patients
This study tests a new way to monitor breathing muscles in patients who need extra oxygen or breathing support, like a mask or high-flow oxygen. It may help doctors better understand how to treat respiratory failure.
LondonAges 18 years+ - NCT06693791RecruitingPhase 2
Romiplostim for platelet recovery after cord blood transplant
This trial tests a drug called Romiplostim N01 to help platelet levels recover faster in people with blood cancers who have had a cord blood transplant. It may reduce the need for platelet transfusions and lower bleeding risk.
Hefei, AnhuiAges 18 years+ - NCT07449039Recruiting
Blood sugar tracking after pregnancy for diabetes risk
This study uses a continuous glucose monitor to track blood sugar for 2 weeks after delivery in women who had gestational diabetes. The goal is to better understand who develops type 2 diabetes later and help prevent it.
Los Angeles, CaliforniaAges 18 years+ - NCT07022236Recruiting
Thyroid Function in Hemodialysis Patients
This study checks thyroid function in people who are on long-term hemodialysis for kidney failure. It aims to see how common thyroid issues are in this group, which could help improve care.
SohagAges 13–80 - NCT04293042RecruitingEarly Phase 1
BK virus treatment using donor immune cells after transplant
This early-phase study tests whether immune cells made from a donor (T cells) can treat BK virus infection in people whose immune system is weak after a stem cell transplant or chemotherapy. It may help control the virus causing bladder/urinary symptoms.
Philadelphia, PennsylvaniaAges 1 month–25 years - NCT06639256RecruitingPhase 1/Phase 2
Testing a new drug for advanced solid tumors
This trial is testing a new drug called HY07121 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
JinanAges 18–80 - NCT07446738Recruiting
Study of recovery and quality of life after nasal polyp surgery
This study looks at how well patients recover and their quality of life after surgery for nasal polyps caused by chronic sinusitis. It is for people in China who have just had surgery to remove nasal polyps.
ChangchunAges Any age - NCT06604052Recruiting
Comparing new stoma surgery techniques for temporary ileostomy
This trial tests a newer, less invasive stoma surgery method against the traditional approach. It aims to see if the new method works better for people who need a temporary ileostomy during colorectal cancer surgery.
Shanghai, ChinaAges 18 years+ - NCT07096479Recruiting
Telpegfilgrastim to prevent low white blood cells in solid tumor patients
This trial tests a once-per-cycle injection (Telpegfilgrastim) to help keep your white blood cell count from dropping dangerously low during chemotherapy. It is for people with solid tumors who are at increased risk for neutropenia (low infection-fighting cells).
Hefei, AnhuiAges 18–70 - NCT06984406Recruiting
Beet product for kidney protection during heart procedure
This trial tests a beet-derived food product (a natural source of nitrate) to see if it can help prevent kidney damage caused by the contrast dye used during a heart procedure called PCI. It is designed for people who already have a higher risk of this kidney problem.
MoscowAges 18 years+ - NCT07614126Recruiting
L-dopa Treatment for Children With CTNNB1 Gene Disorder
This study tests whether L-dopa medication can help children with a rare genetic disorder (caused by changes in the CTNNB1 gene) that causes involuntary muscle movements called dystonia. Researchers want to see if this medicine can reduce these movements and improve daily function.
Montpellier, HéraultAges 1–15 - NCT07425249Recruiting
Chewing gum after stomach or bowel surgery
This trial tests if chewing gum after open stomach or bowel surgery can help your intestines start moving again sooner. It is for people undergoing open gastrointestinal surgery who do not have certain health conditions or take specific medicines.
Peshawar, KPKAges 17–85 - NCT05994274Recruiting
Heart transplant, cholesterol, and organ rejection study
This study looks at whether changes in blood fats (cholesterol and triglycerides) after a heart transplant are linked to the risk of organ rejection. It may help doctors better monitor and protect your new heart.
WuhanAges 18 years+ - NCT07433621RecruitingPhase 1
Quercetin for XIAP deficiency in males ages 2 and up
This trial tests if the supplement quercetin can help patients with XIAP deficiency (an immune condition affecting the body's ability to control cell death and inflammation). It is given as a pill or liquid and might reduce inflammation-related symptoms.
Cincinnati, OhioAges 2 years+ - NCT07444268RecruitingPhase 1
Study of how DSP-5336 is processed in the body in advanced blood cancer patients
This trial looks at how your body absorbs, breaks down, and gets rid of the study drug DSP-5336 after a single dose. It is for people with advanced blood cancers that have come back or not responded to other treatments.
Chapel Hill, North CarolinaAges 18 years+ - NCT04185974Recruiting
Carbon ion re-irradiation for returning head and neck cancer
This trial tests a type of radiation called carbon-ion re-irradiation for people whose head and neck cancer has come back or grown again after earlier radiation. It may help control the cancer after certain surgeries, but it also requires specific safety conditions about timing, prior treatment areas, and overall health.
HeidelbergAges 18 years+ - NCT07408310Recruiting
Spiritual care support for advanced cancer patients
This trial tests whether spiritual care from a chaplain helps people with advanced cancer. If you belong to a faith community and haven't seen a healthcare chaplain recently, you may be able to join.
New York, New YorkAges 18 years+ - NCT06958679RecruitingPhase 1
Study of SYS6005 for advanced solid tumors and lymphomas
This study tests a new drug (SYS6005) that targets a protein called ROR1 on certain cancer cells. It is for people with advanced solid tumors or B-cell lymphomas that have stopped responding to other treatments.
TianjinAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.